Dunvegan Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

Dunvegan Associates’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$32K	Sell	409 -38	-9%	-$2.99K	0.04%	116
2015 Q3	$31K	Hold	447	–	–	0.04%	118
2015 Q2	$40K	Hold	447	–	–	0.04%	108
2015 Q1	$45K	Hold	447	–	–	0.04%	117
2014 Q4	$45K	Sell	447 -1,182	-73%	-$118K	0.04%	112
2014 Q3	$157K	Buy	1,629 +137	+9%	+$13K	0.14%	59
2014 Q2	$139K	Hold	1,492	–	–	0.12%	67
2014 Q1	$124K	Buy	+1,492	New	+$121K	0.1%	70

Other funds holding MJN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dunvegan Associates's MJN Position: Q4 2015 in Review

Dunvegan Associates reduced its Mead Johnson Nutrition Company (MJN) stake by 8.5% in Q4 2015, selling an estimated $2.99K and leaving 409 shares worth $32K. The position accounts for 0.04% of the portfolio, ranked #116.

Dunvegan Associates first reported a position in MJN in Q1 2014 and has held it in 8 quarters since. The position peaked at $157K in Q3 2014. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

Dunvegan Associates held 409 shares of Mead Johnson Nutrition Company worth $32K as of Q4 2015.
Dunvegan Associates sold 38 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $2.99K.
Mead Johnson Nutrition Company made up 0.04% of Dunvegan Associates's portfolio in Q4 2015, its #116 holding.
Dunvegan Associates first reported a position in Mead Johnson Nutrition Company in Q1 2014 and has held it in 8 quarters since.
Dunvegan Associates's Mead Johnson Nutrition Company position peaked at $157K in Q3 2014.
549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.